Emerald Health Therapeutics Announces $25 Million Convertible Debenture Unit Financing

Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has entered into a binding term sheet with a single Canadian institutional accredited…

Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Investor has agreed, subject to certain customary conditions, to purchase 2,500 secured convertible debenture units (each, a “Convertible Debenture Unit”) of the Company at […]

The post Emerald Health Therapeutics Announces $25 Million Convertible Debenture Unit Financing appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *